EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of an LC-MS/MS-Based Analytical Method, In Vitro Characterization, and Pharmacokinetic Study of Rafoxanide Nanosuspension in Sheep

Kairui Sun iD, Bing Li, Fusheng Cheng, Yaxin Zhou iD, Guonian Dai iD, Haiquan Li, Ligang Yuan iD, Jiyu Zhang iD

Animals · 31.03.2026 · 16 (7) · 1065

DOI: 10.3390/ani16071065 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Animals, online erschienen am 31.03.2026. Verfasst von Kairui Sun und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Gansu Agricultural University, Lanzhou 730070, China. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lanzhou Institute of Husbandry and Pharmaceutical Sciences, Department of Science and Technology of Gansu Province, Chinese Academy of Agricultural Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to establish a more sensitive and reliable quantitative method for determining rafoxanide (RFX) in ovine plasma. The method was applied in an 84-day long-term comparative pharmacokinetic trial to evaluate the performance of a rafoxanide nanosuspension (RFX-NS) versus its conventional suspension (RFX-S) in sheep. Characterization of the two formulations revealed the following results: RFX-NS had an average particle size of 484.93 ± 43.11 nm, a uniform size distribution (PDI 0.06 ± 0.07), and a Zeta potential of −43.59 ± 0.67 mV, which were significantly superior to those of RFX-S (particle size 2379.67 ± 121.71 nm, PDI 0.93 ± 0.10, Zeta potential −38.10 ± 0.55 mV), demonstrating excellent physical stability. In vitro dissolution tests indicated a higher dissolution rate for RFX-NS (97.6% at 60 min). By integrating formulation characterization, in vitro dissolution assessment, and pharmacokinetic studies, this research provided a comprehensive analysis of the differences between the two formulations. Pharmacokinetic results showed that, compared to RFX-S, RFX-NS had a significantly reduced apparent volume of distribution (Vz/F: 856.02 ± 274.00 vs. 1404.17 ± 285.1 mL/kg, p < 0.01), a shorter elimination half-life (t1/2: 4.05 ± 1.18 vs. 5.32 ± 0.94 days, p < 0.05), and a relative bioavailability of 128.98%. These findings suggest that RFX-NS is an improved novel formulation superior to the conventional suspension, as it enhances drug efficacy and efficiency by improving drug dissolution and absorption.

Schlagwörter

Stichwörter der Autor:innen

LC-MS/MScharacterizationdissolutionnanosuspensionpharmacokineticsrafoxanidesheep

Autor:innen und Institutionen

  • College of Veterinary Medicine, Gansu Agricultural University, Lanzhou 730070, China.
  • Key Laboratory of Veterinary Pharmaceutical Development, Lanzhou Institute of Husbandry and Pharmaceutical Sciences, Chinese Academy of Agricultural Sciences, Ministry of Agriculture and Rural Affairs, Lanzhou 730050, C…

ORCID-Profile: Kairui Sun, Yaxin Zhou, Guonian Dai, Ligang Yuan, Jiyu Zhang

Förderung

  • Lanzhou Institute of Husbandry and Pharmaceutical Sciences
  • Department of Science and Technology of Gansu Province
  • Chinese Academy of Agricultural Sciences

Zitieren

APA

Sun, K., Li, B., Cheng, F., Zhou, Y., Dai, G., Li, H., Yuan, L., & Zhang, J. (2026). Development of an LC-MS/MS-Based Analytical Method, In Vitro Characterization, and Pharmacokinetic Study of Rafoxanide Nanosuspension in Sheep. Animals, 16(7), 1065. https://doi.org/10.3390/ani16071065

Vancouver

Sun K, Li B, Cheng F, Zhou Y, Dai G, Li H, et al. Development of an LC-MS/MS-Based Analytical Method, In Vitro Characterization, and Pharmacokinetic Study of Rafoxanide Nanosuspension in Sheep. Animals. 2026;16(7):1065. doi:10.3390/ani16071065

BibTeX
@article{Sun2026,
  author = {Sun, Kairui and Li, Bing and Cheng, Fusheng and Zhou, Yaxin and Dai, Guonian and Li, Haiquan and Yuan, Ligang and Zhang, Jiyu},
  title = {Development of an LC-MS/MS-Based Analytical Method, In Vitro Characterization, and Pharmacokinetic Study of Rafoxanide Nanosuspension in Sheep},
  journal = {Animals},
  year = {2026},
  volume = {16},
  number = {7},
  pages = {1065},
  doi = {10.3390/ani16071065}
}
Kostenlos starten →